Remove Compliance Remove Packaging Remove Pharmaceuticals
article thumbnail

Product Highlight: DrugBank on Snowflake Marketplace

DrugBank

At DrugBank, we’re dedicated to empowering pharmaceutical researchers with data that drives impactful results. Your Need for Accessible, High-Quality Data—Solved Pharmaceutical research and healthcare innovation demand timely access to comprehensive, up-to-date data. In fact, poor data quality is estimated to cost U.S.

article thumbnail

The Role of Quality Assurance in Generic Drugs

Drug Patent Watch

The Unsung Heroes of Generic Drugs: The Importance of Quality Assurance As we navigate the complex world of pharmaceuticals, it's easy to overlook the behind-the-scenes efforts that ensure the quality and safety of the medications we rely on.

Drugs 78
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Get Prepared for New Plastic Packaging and Manufacturing Materials Requirements

PPD

In clinical research, the role of drug packaging systems cannot be overlooked. Industry guidelines require biopharmaceutical and biotechnology companies to test their pharmaceutical packaging systems, as the systems often experience prolonged and intimate contact with drug products, drug substances and intermediates.

article thumbnail

WuXi Biologics Unveils WuXiHigh™ 2.0 for Ultra-Concentrated Biologics

The Pharma Data

Meeting the Growing Demand for High-Concentration Biologics High-concentration biologics—generally defined as injectable formulations with protein concentrations exceeding 100 mg/mL—have become a strategic priority for many pharmaceutical developers. WuXiHigh™ 2.0: Pushing the Boundaries With WuXiHigh™ 2.0,

article thumbnail

Best CDMO Practices for Startups: Navigating the Complex World of Contract Development and Manufacturing

Drug Patent Watch

The pharmaceutical landscape is evolving rapidly, with small and medium-sized biotech companies increasingly taking center stage in innovation. Take the time to clearly define your technical needs, from drug substance manufacturing to packaging requirements. How can you ensure your CDMO is up to scratch?

article thumbnail

CMC and the Critical Path to NDA: The Journey from Molecule to Market

The Premier Consulting Blog

Key components of the CMC section The CMC section of an NDA contains detailed information on the following aspects of the investigational drug: Drug substance or active pharmaceutical ingredient (API). Compliance with good manufacturing practices (GMP).

article thumbnail

Exploring the potential of ADCs beyond oncology

Drug Target Review

They provide pharmaceutical companies with the expertise and infrastructure needed to overcome technical, logistical and regulatory hurdles, ensuring efficient development, high-quality standards and timely market entry. By partnering with CDMOs, pharmaceutical companies can share the risks associated with ADC development and manufacturing.

Therapies 119